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Caldesmon is known to inhibit the ATPase activity of actomyosin in a Ca21–calmodulin-regulated
manner. Although a nonmuscle isoform of caldesmon is widely expressed, its functional role has
not yet been elucidated. We studied the effects of nonmuscle caldesmon on cellular contractility,
actin cytoskeletal organization, and the formation of focal adhesions in fibroblasts. Transient
transfection of nonmuscle caldesmon prevents myosin II-dependent cell contractility and induces
a decrease in the number and size of tyrosine-phosphorylated focal adhesions. Expression of
caldesmon interferes with Rho A-V14-mediated formation of focal adhesions and stress fibers as
well as with formation of focal adhesions induced by microtubule disruption. This inhibitory
effect depends on the actin- and myosin-binding regions of caldesmon, because a truncated
variant lacking both of these regions is inactive. The effects of caldesmon are blocked by the
ionophore A23187, thapsigargin, and membrane depolarization, presumably because of the ability
of Ca21–calmodulin or Ca21–S100 proteins to antagonize the inhibitory function of caldesmon on
actomyosin contraction. These results indicate a role for nonmuscle caldesmon in the physiolog-
ical regulation of actomyosin contractility and adhesion-dependent signaling and further dem-
onstrate the involvement of contractility in focal adhesion formation.
INTRODUCTION
The regulation of the interactions between actin filaments
and myosin molecular motors is essential for many cellular
functions, from muscle contraction to signal transduction
(Tan et al., 1992; Brzeska and Korn, 1996; Burridge and
Chrzanowska-Wodnicka, 1996; Squire and Morris, 1998). In
addition to actin and myosin, other actin filament-associated
proteins play basic roles in the regulation of cellular con-
tractility, and these components differ between striated and
smooth muscle and nonmuscle systems. In vertebrate skel-
etal and cardiac muscle, tropomyosins, in association with
the troponin complex, regulate the calcium-sensitive inter-
actions of actin and myosin II (Tobacman, 1996; Squire and
Morris, 1998). In contrast, smooth muscle (as well as non-
muscle) cells do not express the troponin complex, and
regulation of contractility is mediated by at least two inde-
pendent mechanisms involving myosin light chain phos-
phorylation and caldesmon.
The regulation of actomyosin activity in smooth muscle
and nonmuscle cells by phosphorylation of the regulatory
light chain of myosin II (MLC) has been extensively charac-
terized (Tan et al., 1992; Somlyo and Somlyo, 1994). Phos-
phorylation of MLC by Ca21-calmodulin activated myosin
light chain kinase leads to an increase in actomyosin ATPase
activity and triggers myosin II-driven motility in vitro. Re-
cently the small GTPase Rho was established to be a key
regulator of MLC phosphorylation. GTP-bound Rho acti-
vates an enzyme known as Rho-kinase, which phosphory-
lates the myosin-binding subunit of myosin light chain
phosphatase, inactivating it and thereby preventing MLC
dephosphorylation (Kimura et al., 1996). As a result, Rho
activation leads to an accumulation of the phosphorylated
MLC and, subsequently, to the stimulation of actomyosin
ATPase activity.
The second type of regulation of myosin II activity in-
volves caldesmon. This protein has been studied mainly in
smooth muscle cells. Caldesmon contains actin-, myosin-,
tropomyosin-, and Ca21–calmodulin-binding domains and
acts by blocking the interaction of actin with myosin, inhib-
iting actin-activated myosin ATPase activity (for review, see
Huber, 1997; Chalovich et al., 1998; Marston et al., 1998).
‡ These authors contributed equally to this work.
i Corresponding author. E-mail address: libersha@weizmann.
weizmann.ac.il.
© 1999 by The American Society for Cell Biology 3097
Caldesmon has been shown to affect several processes de-
pendent on the actin–myosin interaction, including the
movement of actin filaments over myosin heads as shown
by in vitro motility assays (Okagaki et al., 1991; Haeberle et
al., 1992; Shirinsky et al., 1992; Fraser and Marston, 1995;
Wang et al., 1997) and tension development in skinned
smooth muscle fibers (Katsuyama et al., 1992; Pfitzer et al.,
1993).
Although the majority of experimental data cited above
were obtained using smooth muscle caldesmon, the proper-
ties of nonmuscle caldesmon should be quite similar (for
review, see Matsumura and Yamashiro, 1993; Huber, 1997).
Smooth muscle and nonmuscle caldesmon are expressed
from a single gene via alternative RNA splicing (Hayashi et
al., 1992; Payne et al., 1995), and except for the lack of a
central “spacer” domain, nonmuscle caldesmon contains all
the functionally important domains of the muscle-derived
molecule (Figure 1). However, although studies in smooth
muscle cells strongly suggest a role for caldesmon in the
regulation of contractility, there is no direct evidence for
such a role in nonmuscle cell systems (Huber, 1997). At the
same time, it appears that changes in fibroblast contractility
may proceed without any MLC phosphorylation changes
(Obara et al., 1995), suggesting that regulation of nonmuscle
cell contractility may involve independent alternative mech-
anisms. Nonmuscle caldesmon would constitute a good can-
didate as an alternative regulator of actomyosin contractility.
Contractility of nonmuscle cells has recently been demon-
strated to be intimately associated with adhesion and adhe-
sion-dependent signaling. Focal adhesions are sites of con-
tact between the cell surface and the extracellular matrix,
where the associated actin stress fibers terminate. They com-
prise integrin-type extracellular matrix receptors and a num-
ber of intracellular structural and signaling proteins (for
review, see Geiger et al., 1995; Jockusch et al., 1995; Burridge
and Chrzanowska-Wodnicka, 1996; Ben-Ze’ev and Bershad-
sky, 1997). Rho was shown to be an essential mediator in
pathways leading to formation of focal adhesions and to the
associated focal adhesion–dependent signaling (Ridley and
Hall, 1992; Hotchin and Hall, 1995; Clark et al., 1998). Simi-
larly to the Rho-mediated contractility regulation, the for-
mation of focal adhesions has been shown to depend on
Rho-kinase activation (Leung et al., 1996; Amano et al., 1997;
Ishizaki et al., 1997). Furthermore, chemical inhibitors of
MLC phosphorylation have been shown to prevent Rho-
induced formation of focal adhesions (Chrzanowska-
Wodnicka and Burridge, 1996).
Another body of evidence documenting the role played by
contractility in the regulation of focal adhesion signaling lies
in studies using microtubule disruption as an inducer of
cellular contractility. Microtubule disruption increases con-
tractility in various cell types (Danowski, 1989; Lampidis et
al., 1992; Kolodney and Elson, 1995; Sheridan et al., 1996;
Canman and Bement, 1997). This process is accompanied by
an increase of MLC phosphorylation (Kolodney and Elson,
1995) that can be a consequence of augmentation of Rho
activity (Ren et al., 1999). At the same time, the disruption of
microtubules was shown to be sufficient to induce a rapid
assembly of focal adhesions and downstream adhesion-de-
pendent signaling (Bershadsky et al., 1996; Enomoto, 1996;
Liu et al., 1998). Moreover, the effect of microtubule disrup-
tion on the focal adhesion formation and signaling can be
prevented by the Rho inhibitor C3 botulinum toxin (Eno-
moto, 1996; Liu et al., 1998), as well as by chemical inhibitors
of MLC phosphorylation (Bershadsky et al., 1996). Alto-
gether, these results led us to propose that an increase in cell
Figure 1. Functional domains of nonmuscle caldesmon and a truncated caldesmon variant. Putative functional domains of the nonmuscle
caldesmon molecule were determined by alignment of the nonmuscle and smooth muscle caldesmon using Clustal View software (Higgins
et al., 1991). Tropomyosin-binding domains are shown as open bars; myosin-binding domains are shown as spotty bars (the larger square
spots correspond to stronger binding); actin- and calmodulin-binding domains are indicated by vertically and obliquely hatched bars,
respectively (the density of hatching corresponds to the strength of binding). The digits at the ends of the bars and inside the bars correspond
to the numbers of amino acid residues on caldesmon. The numbers in brackets indicate the following references: [1], Yamashiro et al. (1995);
[2], Wang et al. (1997); [3], Wang et al. (1996); [4], Wang and Chacko (1996); [5], Marston et al. (1994); [6], Mezgueldi et al. (1994); and [7],
Zhuang et al. (1995).
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contractility is an indispensable step in the activation of
adhesion-dependent signaling and focal adhesion forma-
tion.
Thus, most studies investigating the regulation of non-
muscle cell contractility and its relationship to adhesion-
dependent signaling have focused on the role of myosin
light chain phosphorylation and its upstream regulators. We
show here that expression of nonmuscle caldesmon in cul-
tured human fibroblasts inhibits cell contractility, as well as
the assembly of stress fibers and focal adhesions, in a Ca21-
sensitive manner. Thus, nonmuscle caldesmon can control
contractility in fibroblasts and consequently affect adhesion-
dependent signaling. In addition, these data further demon-
strate that stimulation of contractility is an indispensable
step in adhesion-dependent signaling processes.
MATERIALS AND METHODS
Cells
The SV80 cell line, derived from simian virus (SV40)-transformed,
but weakly tumorigenic, human fibroblasts (Kahn et al., 1983) was
used in all the experiments. The cultures were maintained in Dul-
becco’s modified Eagle’s medium supplemented with 10% bovine
calf serum (Hyclone, Logan, UT). Subconfluent cultures were trans-
fected and examined 24–36 h later with or without incubation in
serum-free medium and drug treatment.
cDNA Constructs and Transfections
cDNA clones encoding constitutively active Rho A-V14 kindly pro-
vided by Dr. A. Hall (University College, London, United Kingdom)
and nonmuscle rat caldesmon (Yamashiro et al., 1995), a gift from
Dr. F. Matsumura (Rutgers University, Piscataway, NJ), were PCR
amplified and cloned in-frame between the XbaI and BamHI sites in
the pCGN expression vector with an N-terminal 16-aa hemaggluti-
nin (HA) tag or an 11-aa vesicular stomatitis virus (VSV) tag
(Tanaka and Herr, 1990; Temm-Grove et al., 1996). A scheme de-
picting the localization of actin-, myosin-, tropomyosin-, and Ca21–
calmodulin-binding sites in the sequence of nonmuscle caldesmon
is presented in Figure 1. The caldesmon deletion mutant CD445B
(“truncated caldesmon”) was used as a control. This mutant con-
tains aa 237–445 of nonmuscle caldesmon but lacks the strong
actin-binding sites, the high-affinity Ca21–calmodulin-binding sites,
one of the tropomyosin-binding sites at the C terminus, as well as
the myosin-binding domain at the N terminus (Figure 1). This
deletion mutant of caldesmon was prepared by PCR using sense
primer ACCTTCTAGAGAATTCATGACCCACAAAC (containing
an XbaI site) and antisense primer ACCTGGATCCCTATTCCG-
CAGGGACAGGAAGATC (containing a BamHI site) and subcloned
into the pCGN expression vector as described above.
To visualize caldesmon in living cells a fusion construct compris-
ing caldesmon and the green fluorescent protein (GFP) was created.
GFP cloned into the pRK expression vector was kindly provided by
Dr. B. Geiger (The Weizmann Institute of Science). To produce a
GFP–caldesmon construct, GFP was amplified by PCR from the
pRK vector using sense ACCTTCTAGAATGGTGAGCAAGGGC-
GAGG and antisense ACCTACTAGTTTACTTGTACAGCTCGTC-
CATG primers. The PCR product was digested by XbaI and SpeI and
cloned into the pCGN vector bearing HA-tagged full-length or
truncated CD445B caldesmon in the XbaI site. The GFP bearing pRK
vector was also used as a control in transfection experiments and, in
some cases, in cotransfection experiments with other constructs to
visualize living, transfected cells.
Cells were transfected using Ca21-phosphate or LipofectAMINE
(Life Technologies, Grand Island, NY). Five hours after transfection,
the medium was changed, and the cells were incubated for an
additional time interval in serum-containing or serum-free medium
before experimental treatment or fixation.
Drug Treatment
Microtubule disruption and the consequent induction of focal ad-
hesion formation was achieved by 10 mM nocodazole treatment of
serum-starved cells for 30 min (Bershadsky et al., 1996). To inhibit
Rho activity, C3 Botulinum toxin (10 mg/ml) was added to the
culture in serum-containing medium and incubated overnight. H-7,
a kinase inhibitor shown to suppress cell contractility (Volberg et al.,
1994), was added to the medium for 30 min at a final concentration
of 300 mM. To increase the intracellular Ca21 concentration, cells
were treated with the calcium ionophore A23187 (5 mM) or with the
calcium ATPase inhibitor thapsigargin (1 mM). Alternatively, the
intracellular Ca21 concentration was increased by addition of 50–
100 mM KCl to the culture medium, leading to depolarization of cell
membrane and opening of voltage-gated Ca21 channels (Chen et al.,
1988; De Roos et al., 1997).
Nocodazole [methyl-(5-[2-thienylcarbonyl]-1H-benzimidazol-2-
yl) carbamate] and H-7 [1-(5-isoquinolinylsulfonyl)-2-methylpipera-
zine] were obtained from Sigma (Rehovot, Israel). A23187 and thap-
sigargin were from Calbiochem (La Jolla, CA). Recombinant C3
toxin of Clostridium botulinum was purified as described (Dillon and
Feig, 1995) following expression from a plasmid obtained from Dr.
A. Hall (University College) and was kindly provided to us by Dr.
Ronen Alon (The Weizmann Institute of Science).
Fluorescence Microscopy
Cells were simultaneously fixed and permeabilized in PBS contain-
ing 3% paraformaldehyde and 0.5% Triton X-100 for 2 min, post-
fixed in 3% paraformaldehyde for 20 min, and labeled using indirect
immunofluorescence. Monoclonal antibody to paxillin was pur-
chased from Transduction Laboratories (Lexington, KY), monoclo-
nal anti-phosphotyrosine antibody (clone PT66), anti-VSV antibody
(clone P5D4), FITC- and TRITC-labeled phalloidin from Sigma, and
monoclonal anti-HA tag antibody (clone16B12) from Babco (Rich-
mond, CA). Rabbit anti-phosphotyrosine antibody was kindly pro-
vided by Dr. I. Pecht (The Weizmann Institute of Science), and
polyclonal anti-VSV-G antibody (Soldati and Perriard, 1991) was
provided by Dr. J.-C. Perriard (Swiss Federal Institute of Technol-
ogy, Honggerberg, Switzerland). FITC-, TRITC-, and Cy5-conju-
gated goat anti-mouse and anti-rabbit immunoglobulins were ob-
tained from Jackson Laboratories (West Grove, PA).
Immunolabeling and photography were performed as described
(Volberg et al., 1994). For the immunolabeling of cells double trans-
fected with caldesmon and Rho A-V14, we used the constructs
bearing different tags (VSV and HA) and labeled the cells with
rabbit anti-VSV and mouse anti-HA antibodies, followed by goat
anti-rabbit TRITC-conjugated and anti-mouse Cy5-conjugated anti-
bodies. FITC-phalloidin was used to visualize F-actin in the same
cells. For the visualization of phosphotyrosine in the cells trans-
fected with GFP–caldesmon and VSV–Rho A-V14, we labeled the
cells with mouse anti-VSV and rabbit anti-phosphotyrosine, fol-
lowed by the same combination of secondary antibodies. The triple-
stained specimens were examined by video microscopy using a
Zeiss (Thornwood, NY) Axiovert fluorescence microscope with a
Plan-Apochromat 1003 numerical aperture 1.3 objective, charge-
coupled device camera (Photometrics, Tucson, AZ) and the Priism
and Delta-Vision software packages (Applied Precision, Issaquah,
WA) on a Silicon Graphics computer (SGI, Mountain View, CA). We
used FITC filters to visualize GFP fluorescence.
The Delta-Vision video microscopy system was also used for the
observations of GFP–caldesmon dynamics in living cells. We used
35-mm plastic Petri dishes, in which circular holes were made and
onto which number 1 glass coverslips were mounted with wax to
allow high-resolution visualization. The cells were plated onto these
chambers 5–7 h after the GFP–caldesmon transfection, and the
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observations were performed 16–20 h after plating. The objective
was maintained at 37°C by a regulated electric heater while thermal
contact through the immersion oil held the cells at the same tem-
perature. The medium was buffered by 20 mM HEPES. Dynamics of
GFP–caldesmon was registered by recording the fluorescent images
every 10 min.
Quantitation of Focal Adhesions
To assess semiquantitatively the effects of different treatments and
transfections on the formation and tyrosine phosphorylation of focal
adhesions, we developed a simple classification system. The cells in
each specimen were classified according to the prevailing size of
their focal adhesions, as revealed by anti-phosphotyrosine labeling.
The reference point in this classification was the predominant focal
adhesion size in cells growing in serum-containing medium (Fig-
ures 2A and 3A). A majority of these cells have elongated focal
adhesions of 3–5 mm length and ;1 mm in width. We defined the
cells with prevalent focal adhesions of this size as belonging to the
“medium” class. Cells in which the majority of focal adhesions had
either greater width or length or were bigger in both dimensions
formed the “large” class. Cells with prevalent small dot-like focal
adhesions ,1 mm in size were referred to as the “small” class. For
each type of treatment, 100–200 randomly selected cells were
scored.
Contractility Assays
The traction forces exerted by substrate-attached cells were assessed
using the silicone–rubber substratum method (Harris et al., 1980),
modified according to Burton and Taylor (1997). Briefly, thin films
of silicone rubber were prepared by vulcanizing the surface of a
Figure 2. Effect of caldesmon overexpres-
sion on focal adhesions and the actin cytoskel-
eton of SV80 cells in serum-containing me-
dium. (A and B) cells in control culture; (C–F)
cells transfected with full-length caldesmon;
(G and H) cells transfected with a truncated
variant of caldesmon. Staining was per-
formed with anti-phosphotyrosine (PY) anti-
body (A, C, and G), with FITC-phalloidin (B
and E), and with anti-tag antibody to visual-
ize transfected caldesmon (D, F, and H). (B, D,
F, and H) Photographs of the same fields as in
A, C, E, and G, respectively. Note that focal
adhesions in cells expressing full-length
caldesmon are much smaller than those in
nontransfected cells or in cells expressing the
truncated caldesmon (C compared with A
and G). Stress fibers are abundant in non-
transfected cells (B) but disappear in cells ex-
pressing full-length caldesmon (E and F).
Some caldesmon-transfected cells show an in-
crease in the formation of long processes (E
and F).
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layer of phenylmethyl polysiloxane, trimethyl terminated (710 fluid;
Dow Corning, Midland, MI) with a Bunsen burner flame. Film
compliance was increased by UV irradiation (3 h, at 1 cm from 15-W
lamp; l 5 312 nm). Films were coated with fibronectin (F-1141,
Sigma) by incubation with 10 mg/ml fibronectin solution in PBS for
24 h at 4°C before cell seeding. Cells were transfected with con-
structs encoding GFP–caldesmon, GFP–CD445B (truncated caldes-
mon), or GFP alone and plated on the films 10–20 h before the
observations. The observations were performed using a Plan-Apo-
chromat 403 numerical aperture 1.0 objective and phase-contrast
optics.
To evaluate cell contractility, we also performed live recording of
cell rounding after trypsin treatment (Symons and Mitchison, 1992).
In these experiments the cells were cotransfected with GFP and
caldesmon expression plasmids. Because the efficiency of cotrans-
fection was estimated to be ;95%, as assayed by immunofluores-
cence labeling of cotransfected cells, we assumed that all GFP-
fluorescent cells were also expressing caldesmon. The observations
were performed using a Fluar 1003, numerical aperture 1.3 oil
immersion objective and differential interference contrast optics.
The serum-containing medium was changed to a serum-free me-
dium 1 h before treatment. Standard 0.25% trypsin solution (Bio
Labs, Jerusalem, Israel) was injected into the medium with a final
dilution of 1:5. In these experiments the images were recorded by a
digital charge-coupled device camera (iSight, Tirat haCarmel,
Israel).
RESULTS
Effects of Caldesmon Overexpression on Cell Shape,
the Actin Cytoskeleton, and Focal Adhesions
Subconfluent untreated SV80 cells in serum-containing me-
dium exhibit a polygonal shape and form numerous elon-
gated (dash-like) focal adhesions usually localized at the cell
periphery. These focal adhesions were readily visualized by
immunofluorescence labeling with an anti-phosphotyrosine
antibody (Figure 2A), as well as with antibodies to vinculin
or paxillin (see Figure 9). The actin cytoskeleton of SV80
fibroblasts, revealed by fluorochrome-conjugated phalloi-
din, showed actin filament bundles (“stress fibers”) and a
dense filamentous network localized in lamellipodia at the
leading edges (Figure 2B).
Significant changes in cell shape, adhesion, and actin cy-
toskeletal organization were observed in subconfluent SV80
Figure 3. Botulinum C3 toxin and
the H-7 serine/threonine kinase in-
hibitor induce alterations in cell
morphology, focal adhesions, and
the actin cytoskeleton similar to
those induced by caldesmon trans-
fection. (A and B) Control culture;
(C and D) cells treated with C3
toxin; (E and F) cells treated with
H-7. (A, C, and E) Staining with
anti-phosphotyrosine antibody; (B,
D, and F) staining with FITC-phal-
loidin of the same fields, respec-
tively. Note significant decrease in
the size of focal adhesions and dis-
ruption of actin stress fibers in cells
treated with inhibitors. Note also
that C3 toxin- and H-7-treated cells
exhibit elongated cell processes (D
and F).
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cells transfected with cDNA encoding full-length rat non-
muscle caldesmon (Figure 2, C–F). Transfected cells ac-
quired a characteristic morphology with augmented lamel-
lipodia at the leading edge and elongated tails (Figure 2, D
and F). Some cells with especially high levels of caldesmon
expression became “arborized” because of the formation of
long, slender, and sometimes branching cell processes (our
unpublished results). Phalloidin staining of caldesmon-
transfected cells revealed different stages of actin cytoskele-
ton disorganization. At 12–15 h after transfection, alterations
in morphology were not yet very pronounced, and the trans-
fected caldesmon in many cells was associated with normal
actin-containing structures, including stress fibers. After
24–48 h of incubation, however, only a few caldesmon-
transfected cells showed well-developed straight stress
fibers, whereas the majority of cells exhibited altered,
thin, and wavy stress fibers, to which the caldesmon
remained associated or demonstrated diffuse distribution
of both actin and caldesmon (Figure 2, E and F). The
truncated variant of caldesmon, CD445B, incorporated to
some extent into stress fibers, although nuclear and dif-
fuse cytoplasmic staining was more pronounced than in
the case of full-length caldesmon (Figure 2H). Transfec-
tion with CD445B did not produce apparent changes in
the actin cytoskeleton.
Anti-phosphotyrosine labeling showed that tyrosine
phosphorylation in caldesmon-overexpressing cells was sig-
nificantly lower than in control cells (Figure 2, C compared
with A). Phosphotyrosine-containing focal adhesions in
these cells were small, dot-like, and localized mainly at the
edges of lamellipodial protrusions (Figure 2C). Transfection
of cells with the truncated variant of caldesmon, CD445B,
did not interfere with formation and tyrosine phosphoryla-
tion of focal adhesions (Figure 2G).
Figure 4. Caldesmon prevents develop-
ment of traction forces in cells attached to
an elastic silicone–rubber substrate. Cells
were plated onto a fibronectin-coated sili-
cone–rubber film 7 h after transfection
with GFP-caldesmon (A–D), truncated
caldesmon GFP–CD445B (E and F), or GFP
alone (G and H) and photographed 20 h
later. (A, C, E, and G) Phase-contrast im-
ages of substrate-attached cells and wrin-
kles they produce. (B, D, F, and H) GFP
fluorescence images of the same fields
showing that cells expressing full-length
GFP–caldesmon cannot deform the sub-
strate, whereas cells expressing truncated
caldesmon, or GFP alone readily form
wrinkles. Bar, 20 mm.
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The results of cell treatment with the protein kinase in-
hibitor H-7 and with the Rho inhibitor C3 botulinum toxin
showed a striking similarity to the phenotypic effects of
caldesmon overexpression (Figure 3). Treatment with these
inhibitors led to an increase of protrusion activity, formation
of elongated thin processes, and deterioration of stress fibers
(Figure 3, D and F). The cells also failed to form large,
dash-like focal adhesions, and labeling with anti-phospho-
tyrosine antibody revealed only small dot-like peripheral
focal contacts (Figure 3, C and E compared with A).
Caldesmon Inhibits Cell Contractility
The contractility of caldesmon-transfected cells was assessed
by examining the ability of substrate-attached cells to gen-
erate traction forces. This was analyzed in cells plated on
elastic silicone rubber films after transfection with a con-
struct encoding GFP–caldesmon (Figure 4). Formation of
wrinkles on the silicone rubber film because of cell traction
depends on the local compliance of the film. Because this
parameter can vary from film to film and even from one area
to another on the same film, we assessed the behavior of
transfected cells only in the fields in which 100% of non-
transfected neighboring cells exhibited apparent ability to
form the wrinkles. Under these circumstances, the cells
transfected with GFP– caldesmon demonstrated a se-
verely depressed ability to produce wrinkles, and ;90%
of them did not induce wrinkling at all (Figure 4, A and
C). Under the same conditions, ;80% of cells transfected
with truncated caldesmon 445B were able to induce wrin-
kles (Figure 4E). The expression of GFP alone did not
interfere with the ability of cells to generate wrinkles
(Figure 4G).
Another assay used to demonstrate an inhibitory effect
of caldesmon on cell contractility was trypsin-induced cell
rounding. Trypsin treatment induces a rapid contraction
in the majority of cell types, leading to complete cell
rounding. Cell rounding depends on an actin–myosin
interaction, as was shown on permeabilized cells (Sims et
al., 1992). Signals inducing rounding activate MLC phos-
phorylation in a Rho-dependent manner (Majumdar et al.,
1998). The rounding assay is convenient for analysis of
actomyosin-driven cell contractility (Symons and Mitchi-
son, 1992). As shown in Figure 5, the transfected cells did
not round up after addition of trypsin, whereas neighbor-
ing, nontransfected cells became round in ,2 min under
these conditions (Figure 5, E and F compared with A and
B). The rounding of cells transfected with GFP alone was
not retarded when compared with the rounding of their
nontransfected neighbors (our unpublished results).
Caldesmon-transfected cells treated with 50 mM KCl for
Figure 5. Caldesmon transfection pre-
vents cell rounding induced by trypsin
treatment. SV80 cells cotransfected with
caldesmon and GFP were incubated in
serum-free medium and treated with
trypsin. Images were captured using flu-
orescence microscopy to identify trans-
fected cells (A and F) and differential in-
terference contrast optics to follow the
changes in cell morphology induced by
the treatment (B–E). (A and B) Culture
before trypsin treatment; note transfected
cell visualized by fluorescence in A.
(C–E) Same field after 40, 80, and 120 s of
trypsin treatment, respectively. (F) Fluo-
rescence image corresponding to E. Note
that the nontransfected cells retract and
become round upon trypsin treatment,
whereas the caldesmon-transfected cell
does not significantly change shape
(compare A and F).
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30 min before trypsin addition demonstrated a rate of cell
rounding similar to that of neighboring nontransfected
cells (our unpublished results).
Caldesmon Prevents Formation of Focal Adhesions
and Stress Fibers Induced by Activated Rho or by
Microtubule Disruption
Transfection of SV80 cells with a cDNA encoding the con-
stitutively activated Rho A-V14 induced dramatic changes
in the organization of the actin cytoskeleton and focal adhe-
sions, both in serum-free and in ordinary serum-containing
medium. The transfected Rho A-V14 was diffusely distrib-
uted over the entire cytoplasm (Figures 6 and 7), as previ-
ously described (Adamson et al., 1992). Phalloidin staining
revealed very large bundles of actin in the Rho A-V14-
transfected cells (Figure 6B).
To investigate the effects of caldesmon expression on the
Rho-dependent formation of stress fibers and focal adhe-
sions, cells were cotransfected with two different constructs,
one encoding caldesmon, and the other encoding Rho A-
V14. Double indirect immunofluorescence labeling of the
cotransfected cells showed that 95% of the transfected cells
expressed both proteins, although the level of expression of
each varied between cells. Triple staining of tagged-Rho
A-V14 and caldesmon together with F-actin allowed us to
analyze the organization of the actin cytoskeleton with re-
spect to the different ratios of Rho and caldesmon expression
(Figure 6, C–F). These data showed that the expression of
caldesmon could inhibit or even completely abolish the ef-
fect of Rho on cell morphology and the assembly of actin
bundles. The cells expressing a high level of caldesmon did
not form prominent actin stress fibers, even in the presence
of comparable levels of Rho A-V14 (Figure 6, C–F). In addi-
tion, cells coexpressing Rho A-V14 and caldesmon often
exhibited a shape similar to that of cells expressing caldes-
mon alone, with numerous lamellipodia and elongated pro-
cesses (Figure 6, E and F). On the other hand, in the presence
of low or intermediate levels of caldesmon, high expression
of Rho still correlated with the display of stress fibers (Figure
6, C and D, left cell).
Cells doubly transfected with Rho A-V14 and caldes-
mon often showed small, dot-like focal adhesions (Figure
Figure 6. Caldesmon interferes
with Rho-induced enhancement of
actin cable formation. (A and B)
Cells transfected with activated Rho
(Rho A-V14). Staining was per-
formed with anti-tag antibody to vi-
sualize Rho A-V14 expression (A)
and with phalloidin to visualize ac-
tin in the same cells (B). (C–F) Cells
cotransfected with activated Rho
and caldesmon. Triple staining was
performed to visualize Rho, caldes-
mon, and F-actin in the same cul-
tures. (C and E) Staining with anti-
bodies to VSV and HA tag
visualizing transfected Rho and
caldesmon; intensities of staining are
represented by pseudo colors: red
corresponds to 100% Rho; green cor-
responds to 100% caldesmon; and
intermediate orange–yellow colors
correspond to different ratios be-
tween them. (D and F) Phalloidin
staining of the same fields. Bar, 25
mm. Note that stress fibers in Rho-
transfected cells (B) are much better
developed than in neighboring (non-
transfected) cells. The cells cotrans-
fected with Rho and caldesmon as-
semble actin cables only if the level
of Rho is much higher than the level
of caldesmon (cell in the upper left
part of C and D); if the level of
caldesmon is comparable with that
of Rho, formation of actin cables is
blocked (cells in E and F).
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7A) typical of cells transfected with caldesmon alone (Fig-
ure 2C). Truncated CD445B caldesmon did not interfere
with Rho-dependent stimulation of focal adhesion forma-
tion (Figure 7D). The effect of caldesmon and Rho A-V14
on the focal adhesions was quantified by classifying the
cells according to the size of their focal adhesions after
labeling with anti-phosphotyrosine antibody (see MATE-
RIALS AND METHODS); the percentage of cells display-
ing each phenotype in the population of transfected cells
was determined (Figure 8). These data showed that the
cells expressing active Rho A-V14 all presented oversized
focal adhesions when compared with mock-transfected
cells (Figure 8, A and B). More interestingly, ;50% of the
cells cotransfected with caldesmon and Rho exhibited
tyrosine-phosphorylated focal adhesions that were
smaller than those of cells transfected with Rho alone
(Figure 8D). On the other hand, the fraction of cells with
large focal adhesions was still higher in the population of
doubly transfected cells when compared with the popu-
lation of cells transfected with caldesmon alone (Figure 8,
D compared with C). Thus, overexpression of full-length
caldesmon efficiently inhibited formation of stress fibers
and the phosphotyrosine-positive focal adhesions in-
duced by activated Rho, but Rho also can partially sup-
press the effects of caldesmon.
We have previously shown that adhesion-dependent
signaling, which includes formation of stress fibers and
focal adhesions, is activated in serum-starved 3T3 fibro-
blasts by microtubule disruption (Bershadsky et al., 1996).
Microtubule disruption was shown to induce Rho activa-
tion (Ren et al., 1999), MLC phosphorylation, and cell
contraction (Danowski, 1989; Kolodney and Elson, 1995).
We compared the effect of microtubule disruption on the
formation of focal adhesions in control and caldesmon-
transfected cells. SV80 cells were transfected with GFP–
caldesmon, serum starved for 24 h, and treated with no-
codazole for 30 min. Caldesmon-transfected cells, in
contrast to the controls, did not form large phosphoty-
rosine- or paxillin-positive focal adhesions upon microtu-
bule disruption (Figure 9, A and B). Scoring the cells
according to the size of their focal adhesions showed that
in serum-free medium, control or caldesmon-transfected
SV80 cells formed mainly small focal adhesions (Figure
10, A and B). Addition of nocodazole induced the forma-
tion of numerous large focal adhesions in control cells,
whereas caldesmon-expressing cells were much less af-
fected (Figure 10, D compared with C). The difference
between nocodazole-induced focal adhesion formation in
mock-transfected and caldesmon-transfected cells was
highly significant (x2 5 82; p # 0.001). Thus, caldesmon
expression, similar to chemical inhibitors that suppress
cell contractility (Bershadsky et al., 1996), can efficiently pre-
vent the induction of focal adhesions by nocodazole.
Figure 7. Effect of caldesmon expression on the Rho-induced formation of focal contacts. Triple labeling was performed to visualize
phosphotyrosine (A and D), VSV-tagged Rho A-V14 (B and E), and GFP–caldesmon in the same cells. (A–C) Cells cotransfected with
activated Rho and full-length GFP-caldesmon show predominantly dot-like focal adhesions. (D–F) Cells cotransfected with activated Rho and
truncated GFP–CD445B caldesmon form large and intensely stained focal adhesions. Bar, 25 mm.
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The Effects of Caldesmon on Focal Adhesions and
Stress Fibers Are Ca21 Sensitive
The inhibitory effect of caldesmon on the ATPase activity of
actomyosin is reversible by calmodulin, calmodulin-like
Ca21-binding protein, or S100 in the presence of Ca21 (Mar-
ston et al., 1998). Here we show that increased intracellular
Ca21 can reverse the inhibitory effects of transfected caldes-
mon on the assembly of stress fibers and focal adhesions. To
investigate whether the effects of caldesmon in vivo are
Ca21 sensitive, we used several experimental procedures
that increase the intracellular Ca21 concentration via various
mechanisms. These include treatment with the calcium iono-
phore A23187, with Ca21–ATPase inhibitor thapsigargin,
which releases Ca21 from intracellular stores (Treiman et al.,
1998), and with KCl, which induces membrane depolariza-
tion and opening of voltage-gated calcium channels.
All these treatments efficiently reversed the effects of over-
expressed caldesmon. Caldesmon transfection, as described
above, disorganized the actin cytoskeleton; as a result, GFP–
caldesmon exhibited diffuse distribution with slightly in-
creased intensity along a few wavy stress fiber remnants
(Figure 11A). Video microscopic examination of GFP–
caldesmon dynamics showed that thapsigargin (Figure 11)
or KCl (our unpublished results) induced rapid recovery of
the normal cytoskeleton structure with prominent
caldesmon-containing stress fibers (Figure 11, B–F). This
result demonstrates that caldesmon remains associated
with the actin filament bundles even under conditions
when its inhibitory effect on actin-myosin interaction is
blocked by Ca21.
Treatment with the calcium-mobilizing compounds inter-
fered with the inhibitory effect of caldesmon on focal adhe-
sions. The percentage of cells with medium or large focal
adhesions increased, whereas the percentage of cells with
small focal adhesions decreased in caldesmon-transfected
cells after KCl treatment (Figure 10, E and F). Increased
intracellular Ca21 abolished the inhibitory effect of caldes-
mon on formation of focal adhesions induced by microtu-
bule disruption. When A23187 or thapsigargin was added to
the medium before the nocodazole treatment, both trans-
fected and nontransfected cells developed elongated mature
focal adhesions of similar size (Figure 9, D and F). Formation
of prominent focal adhesions in nocodazole-treated cells
with elevated levels of intracellular Ca21 was accompanied
by the assembly of stress fibers to which GFP–caldesmon
was localized (Figure 9, C and E). Collectively, these results
demonstrate the calcium sensitivity of the inhibitory effect of
caldesmon on focal adhesions and stress fibers.
DISCUSSION
Previous studies of contractility in nonmuscle cells have
focused mainly on phosphorylation of the regulatory light
chain of myosin. Here we demonstrate that regulation of
contractility can occur through a mechanism involving non-
muscle caldesmon. We have shown that both generation of
Figure 8. Quantification of effects of Rho and
caldesmon on focal adhesions visualized by anti-
phosphotyrosine staining. The percentage of cells
having small, medium, and large focal adhesions
was scored. Small refers to dot-like, nonelongated
plaques; medium corresponds to typical dash-like
adhesions in cultures of SV80 cells in serum-contain-
ing medium; and large denotes very large streak-like
focal adhesions, typical of Rho-transfected cells.
Note that Rho transfection induces formation of
large focal adhesions in all cells (compare A and B),
whereas caldesmon transfection efficiently decreases
the percentage of cells with large focal adhesions,
even in cells expressing activated Rho (C and D).
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traction forces by cells attached to flexible film and cell
rounding after trypsin treatment were suppressed in the
cells transfected with a construct encoding caldesmon. Over-
expression of caldesmon was also able to inhibit contractility
induced by microtubule disruption and expression of active
Rho A-V14. Some caldesmon-transfected cells acquire a typ-
ical arborized shape with characteristic branching processes;
this is likely to be a consequence of the inability of the cells
with impaired contractility to retract their lamellipodial ex-
tensions and trailing edges (“tails”) during locomotion.
Comparable morphological changes were previously ob-
served in cells microinjected with antibodies against myosin
II (Honer et al., 1988) or treated with chemical inhibitors that
block myosin II-driven contractility (Volberg et al., 1994).
The apparent similarity between the morphological effects of
these different agents strongly suggests that the changes in
cell shape they induced are all related to their inhibitory
effect on cell contractility.
Previous studies have localized endogenous caldesmon to
actin filaments in cultured cells (Bretscher and Lynch, 1985;
Yamashiro-Matsumura and Matsumura, 1988; Hosoya et al.,
1993). Our results with caldesmon overexpression are con-
sistent with these observations. At early time points after
transfection caldesmon is localized to stress fibers. Later, at
24–48 h after transfection, caldesmon exhibits its effects on
stress fiber organization: straight, thick stress fibers gradu-
ally disappear and are replaced by less-defined wavy bun-
dles of actin filaments, to which the exogenous caldesmon
remains associated. It is interesting to note, however, that
when the effect of caldesmon is blocked by elevated cyto-
plasmic Ca21 levels (see below), the prominent stress fibers
appear again, and exogenous caldesmon is still found asso-
ciated to them. This result shows that the association of
nonmuscle caldesmon with stress fibers is preserved even
under conditions when its function is suppressed by Ca21–
calmodulin. This is in agreement with studies in smooth
muscle in which it was demonstrated that caldesmon re-
mains associated with thin filaments in the presence of Ca21
complex with calmodulin-like Ca21-binding protein (Mar-
ston et al., 1998).
Figure 9. Effect of caldesmon on the stimulation
of focal adhesion formation by nocodazole. Cells
were transfected with GFP–caldesmon and serum
starved for 24 h before nocodazole treatment. Af-
ter treatment the cells were fixed and stained with
mouse monoclonal antibodies against paxillin. (A,
C, and E) GFP–caldesmon fluorescence is visual-
ized; (B, D, and F) staining of the same fields with
anti-paxillin antibody is presented. Bar, 20 mm. (A
and B) Incubation with 10 mM nocodazole for 30
min induced formation of prominent focal adhe-
sions in nontransfected cells (B, right cell) but not
in the cells transfected with caldesmon (B, left
cell). (C–F) Increased intracellular Ca21 interferes
with the inhibitory effect of caldesmon on focal
adhesion and stress fiber formation. Five micro-
molar A23187 (C and D) or 1 mM thapsigargin (E
and F) was added to the medium for 1 h before
incubation with 10 mM nocodazole for an addi-
tional 30 min. Note that incubation with either
A23187 or thapsigargin restores the ability of
caldesmon-transfected cells to form large focal ad-
hesions and stress fibers after nocodazole treat-
ment (compare B with D and F). Caldesmon in the
cells treated with calcium-mobilizing agents is lo-
calized to stress fibers (C and E).
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We found that caldesmon-transfected cells, in the pres-
ence of serum, exhibit smaller focal adhesions with reduced
levels of tyrosine-phosphorylated proteins compared with
the nontransfected cells. These dot-like focal adhesions are
usually concentrated at the leading edge and associated with
poorly defined actin structures. This phenotype was essen-
tially the same as that induced by chemical inhibitors of
myosin-II-driven contractility or by Rho inactivation (Ridley
and Hall, 1992; Volberg et al., 1994; Bershadsky et al., 1996;
Chrzanowska-Wodnicka and Burridge, 1996; Pelham and
Wang, 1997). Moreover, we have shown that caldesmon
overexpression prevents the induction of focal adhesions
and stress fibers by activated Rho or by microtubule disrup-
tion. Thus, inhibition of actomyosin contractility by caldes-
mon leads to the dissolution of preexisting focal adhesions
and blocks their formation. These results, together with
experiments using inhibitors of MLC phosphorylation (Ber-
shadsky et al., 1996; Chrzanowska-Wodnicka and Burridge,
1996; Pelham and Wang, 1997), strongly suggest that the
maintenance and assembly of focal adhesions depend on
myosin II-driven contractility. It is worth noting that caldes-
mon has an advantage as an experimental tool over chemical
inhibitors of myosin II function, because it is a natural and
specific inhibitor of actomyosin contractility.
The specificity of the effects of nonmuscle caldesmon is
supported by the following observations. First, these effects
are Ca21 sensitive, because they can be abrogated by in-
creasing the cytoplasmic Ca21 concentration. This character-
istic is in agreement with the known calcium sensitivity of
caldesmon effects in vitro mediated by Ca21-binding pro-
teins such as calmodulin or S100 (Smith et al., 1987; Pritchard
and Marston, 1991; Marston et al., 1998). Elevations of intra-
Figure 10. Quantification of the effects
of caldesmon on the stimulation of focal
adhesion formation by nocodazole and
KCl treatment. Cells stained with anti-
phosphotyrosine antibody and with an-
ti-tag antibody visualizing transfected
caldesmon were analyzed. The percent-
age of cells with small, medium, and
large focal adhesions was scored. The
diagram shows that transfection with
caldesmon prevents stimulation of focal
adhesion assembly by nocodazole,
whereas stimulation by KCl is less se-
verely affected.
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cellular Ca21 could also be expected to lead to the stimula-
tion of actomyosin ATPase through an increased phosphor-
ylation of MLC by myosin light chain kinase (Tan et al., 1992;
Somlyo and Somlyo, 1994) and thereby indirectly counteract
the effects of caldesmon on contractility. However, caldes-
mon still inhibits actomyosin ATPase and movement of
actin filaments on smooth muscle myosin even if MLC is
phosphorylated (Okagaki et al., 1991; Shirinsky et al., 1992).
Thus we can attribute the observed restoration of actomyo-
sin contractility to the effect of Ca21 on caldesmon via Ca21-
binding proteins.
Second, the truncated caldesmon CD445B mutant, lacking
both a myosin-binding domain at the N terminus and a
strong actin-binding site at the C terminus, does not exhibit
any detectable biological activity in our experiments. In
contrast, transfections with constructs containing either all
the actin-binding sites of the molecule or truncated actin-
binding domains together with intact myosin-binding do-
mains at the N terminus are sufficient to produce phenotypic
alterations similar to those induced by full-length caldesmon
(our unpublished results). Detailed analysis of the in vivo
functions of the different domains of nonmuscle caldesmon
will require further work, but these observations clearly
establish that the observed effects of caldesmon expression
are due to its interactions with actin and myosin.
Thus, our results provide significant new evidence for the
role of contractility in maintenance and formation of focal
adhesions. The possible mechanisms underlying the rela-
tionship between contractility and the assembly of focal
adhesions have been extensively discussed in the literature
(Bershadsky et al., 1996; Burridge and Chrzanowska-
Wodnicka, 1996; Chrzanowska-Wodnicka and Burridge,
1996; Ben-Ze’ev and Bershadsky, 1997; Chicurel et al., 1998;
Elbaum et al., 1998). A plausible suggestion is that the main-
tenance of focal adhesions depends on the tension devel-
oped by the actomyosin system, or, in other words, that focal
adhesions belong to the class of “tensegrity” structures that
preserve their integrity only under tension (Ingber, 1997).
Involvement of the cytoskeletal tensegrity in inte-
grin-dependent signaling was proposed by Ingber (1991,
1997) and Chicurel et al. (1998). In our model (Bershadsky et
al., 1996; Elbaum et al., 1998) the nascent adhesive contacts in
association with the actin cytoskeleton operate as tension-
sensing devices converting mechanical signals into protein
modification (such as tyrosine phosphorylation) and thus
activate downstream intracellular pathways. The impor-
tance of tension for triggering adhesion-dependent signal
transduction is supported by recent findings in which exter-
nal forces applied to the cell–extracellular matrix adhesion
sites, such as stretching of an elastic substrate (Hamasaki et
al., 1995; MacKenna et al., 1998) or trapping of cell surface-
attached beads (Choquet et al., 1997; Schmidt et al., 1998;
Suter et al., 1998), were shown to increase the strength of
adhesion itself, the phosphorylation of focal adhesion pro-
teins, and the progress of downstream signaling events. In
addition, plating of cells on a very flexible substrate sup-
pressed tension development and inhibited the formation
and tyrosine phosphorylation of focal adhesions (Pelham
and Wang, 1997). Collectively, these studies show that the
tension-sensing molecular device, comprising focal adhe-
sions and the actin cytoskeleton, has an important regula-
tory role in eukaryotic cells. This mechanism is under the
control of several regulatory pathways, and we show here
that caldesmon plays an important role in the regulation of
this mechanism.
Caldesmon may be a target for a variety of signaling
pathways that modulate its function and thereby its effect on
cell contractility and adhesion-dependent signaling. Besides
the calcium-sensitive regulation discussed above, it is
known that caldesmon can be phosphorylated by serine/
threonine kinases, including MAPK (Gerthoffer et al., 1996),
p34cdc2 (Yamashiro et al., 1991), p21-activated protein kinase
Figure 11. Reversal of the caldesmon
effect by thapsigargin. GFP–caldesmon
distribution in the transfected cell was
visualized using video microscopy be-
fore (A) and 3 (B), 15 (C), 30 (D), 50 (E),
and 70 (F) min after addition of thapsi-
gargin. Note the absence of prominent
stress fibers in the caldesmon-trans-
fected cells and their recovery after
thapsigargin treatment. Bar, 15 mm.
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(Van Eyk et al., 1998), and tyrosine kinases (McManus et al.,
1997). In some cases, this phosphorylation was shown to
affect caldesmon function (for review, see Matsumura and
Yamashiro, 1993). In the future, it will be of interest to
determine whether caldesmon is a target for phosphoryla-
tion during activation of signaling pathways dependent on
contractility, such as the Rho-dependent pathway.
Finally, tropomyosins are likely to play a significant
role in the modulation of caldesmon function. Tropomyo-
sins are natural partners of caldesmon in the regulation of
actomyosin-based contractility and, indeed, can mediate
the inhibitory effects of caldesmon on actomyosin (Horiu-
chi et al., 1995; Hodgkinson et al., 1997; Marston et al.,
1998). In nonmuscle cells, the diversity of tropomyosins is
very large (Pittenger et al., 1994; Gunning et al., 1997; Lin
et al., 1997), and caldesmon specifically interacts with
particular isoforms (Yamashiro-Matsumura and Mat-
sumura, 1988; Novy et al., 1993; Pittenger et al., 1995), the
biological significance of which remains unclear. Based on
our results demonstrating the ability of caldesmon to
regulate adhesion-dependent signaling, we suggest that
specific tropomyosins could be important in maintaining
the normal signaling function in the cell. This may pro-
vide a clue to explain the enigmatic correlation between
the spectrum of tropomyosin isoforms and neoplastic
transformation (Prasad et al., 1993; Braverman et al., 1996;
Gimona et al., 1996; Janssen and Mier, 1997).
Future studies will determine more precisely how caldes-
mon contributes to the regulation of nonmuscle cell contrac-
tility, how its function is regulated, and what role caldesmon
plays in the signaling cascades associated with adhesion-
mediated signal transduction.
ACKNOWLEDGMENTS
We thank Avri Ben-Ze’ev and Benny Geiger for encouragement and
interesting discussions, Fumio Matsumura for the nonmuscle
caldesmon cDNA, and Alan Hall for Rho A-V14 and C3 toxin
cDNA. These studies were supported in part by grants from Min-
erva Foundation, Israel Science Foundation, Israel Ministry of Sci-
ence, and La Fondation Rapael et Regina Levy (to A.D.B.). Partici-
pation of M.E. was supported in part by the Israel Science
Foundation and by the G.M.J. Schmidt Minerva Center for Su-
pramolecular Architecture. C.B. is the recipient of a postdoctoral
fellowship from the American Heart Association, New York State
Affiliate. D.M.H. is supported by National Cancer Institute grant
CA58607 and was the recipient of a Michael visiting professorship
from the Weizmann Institute of Science.
REFERENCES
Adamson, P., Paterson, H.F., and Hall, A. (1992). Intracellular local-
ization of the p21rho proteins. J. Cell Biol. 119, 617–627.
Amano, M., Chihara, K., Kimura, K., Fukata, Y., Nakamura, N.,
Matsuura, Y., and Kaibuchi, K. (1997). Formation of actin stress
fibers and focal adhesions enhanced by Rho-kinase. Science. 275,
1308–1311.
Ben-Ze’ev, A., and Bershadsky, A.D. (1997). The role of the cytoskel-
eton in adhesion-mediated signaling and gene expression. Adv.
Mol. Cell Biol. 24, 125–163.
Bershadsky, A., Chausovsky, A., Becker, E., Lyubimova, A., and
Geiger, B. (1996). Involvement of microtubules in the control of
adhesion-dependent signal transduction. Curr Biol. 6, 1279–1289.
Braverman, R.H., Cooper, H.L., Lee, H.S., and Prasad, G.L. (1996).
Antioncogenic effects of tropomyosin: isoform specificity and im-
portance of protein coding sequences. Oncogene 13, 537–545.
Bretscher, A., and Lynch, W. (1985). Identification and localization
of immunoreactive forms of caldesmon in smooth and nonmuscle
cells: a comparison with the distributions of tropomyosin and al-
pha-actinin. J. Cell Biol. 100, 1656–1663.
Brzeska, H., and Korn, E.D. (1996). Regulation of class I and class II
myosins by heavy chain phosphorylation. J. Biol. Chem. 271, 16983–
16986.
Burridge, K., and Chrzanowska-Wodnicka, M. (1996). Focal adhe-
sions, contractility, and signaling. Annu. Rev. Cell Dev. Biol. 12,
463–518.
Burton, K., and Taylor, D.L. (1997). Traction forces of cytokinesis
measured with optically modified elastic substrata. Nature 385,
450–454.
Canman, J.C., and Bement, W.M. (1997). Microtubules suppress
actomyosin-based cortical flow in Xenopus oocytes. J. Cell Sci. 110,
1907–1917.
Chalovich, J.M., Sen, A., Resetar, A., Leinweber, B., Fredricksen,
R.S., Lu, F., and Chen, Y.D. (1998). Caldesmon: binding to actin and
myosin and effects on elementary steps in the ATPase cycle. Acta
Physiol. Scand. 164, 427–435.
Chen, C.F., Corbley, M.J., Roberts, T.M., and Hess, P. (1988). Volt-
age-sensitive calcium channels in normal and transformed 3T3 fi-
broblasts. Science. 239, 1024–1026.
Chicurel, M.E., Chen, C.S., and Ingber, D.E. (1998). Cellular control
lies in the balance of forces. Curr. Opin. Cell Biol. 10, 232–239.
Choquet, D., Felsenfeld, D.P., and Sheetz, M.P. (1997). Extracellular
matrix rigidity causes strengthening of integrin-cytoskeleton link-
ages. Cell 88, 39–48.
Chrzanowska-Wodnicka, M., and Burridge, K. (1996). Rho-stimu-
lated contractility drives the formation of stress fibers and focal
adhesions. J. Cell Biol. 133, 1403–1415.
Clark, E.A., King, W.G., Brugge, J.S., Symons, M., and Hynes, R.O.
(1998). Integrin-mediated signals regulated by members of the rho
family of GTPases. J. Cell Biol. 142, 573–586.
Danowski, B. (1989). Fibroblast contractility and actin organization
are stimulated by microtubule inhibitors. J. Cell Sci. 93, 255–266.
De Roos, A., Willems, P.H., van Zoelen, E.J., and Theuvenet, A.P.
(1997). Synchronized Ca21 signaling by intercellular propagation of
Ca21 action potentials in NRK fibroblasts. Am J Physiol. 273,
C1900–C1907.
Dillon, S.T., and Feig, L.A. (1995). Purification and assay of recom-
binant C3 transferase. Methods Enzymol. 256, 174–184.
Elbaum, M., Chausovsky, A., Levy, E.T., Shtutman, M., and Ber-
shadsky, A.D. (1998). Microtubule involvement in regulating cell
contractility and adhesion-dependent signaling: a possible mecha-
nism for polarization of cell motility. Biochem. Soc. Symp. 65, 147–
172.
Enomoto, T. (1996). Microtubule disruption induces the formation
of actin stress fibers and focal adhesions in cultured cells: possible
involvement of the rho signal cascade. Cell Struct. Funct. 21, 317–
326.
Fraser, I.D., and Marston, S.B. (1995). In vitro motility analysis of
smooth muscle caldesmon control of actin-tropomyosin filament
movement. J. Biol. Chem. 270, 19688–19693.
Geiger, B., Yehuda-Levenberg, S., and Bershadsky, A.D. (1995).
Molecular interactions in the submembrane plaque of cell-cell and
cell-matrix adhesions. Acta Anat. 154, 46–62.
D.M. Helfman et al.
Molecular Biology of the Cell3110
Gerthoffer, W.T., Yamboliev, I.A., Shearer, M., Pohl, J., Haynes, R.,
Dang, S., Sato, K., and Sellers, J.R. (1996). Activation of MAP kinases
and phosphorylation of caldesmon in canine colonic smooth mus-
cle. J. Physiol. 495, 597–609.
Gimona, M., Kazzaz, J.A., and Helfman, D.M. (1996). Forced expres-
sion of tropomyosin 2 or 3 in v-Ki-ras-transformed fibroblasts re-
sults in distinct phenotypic effects. Proc. Natl. Acad. Sci. USA 93,
9618–9623.
Gunning, P., Weinberger, R., and Jeffrey, P. (1997). Actin and tro-
pomyosin isoforms in morphogenesis. Anat. Embryol. 195, 311–315.
Haeberle, J.R., Trybus, K.M., Hemric, M.E., and Warshaw, D.M.
(1992). The effects of smooth muscle caldesmon on actin filament
motility. J. Biol. Chem. 267, 23001–23006.
Hamasaki, K., Mimura, T., Furuya, H., Morino, N., Yamazaki, T.,
Komuro, I., Yazaki, Y., and Nojima, Y. (1995). Stretching mesangial
cells stimulates tyrosine phosphorylation of focal adhesion kinase
pp125FAK. Biochem. Biophys. Res. Commun. 212, 544–549.
Harris, A.K., Wild, P., and Stopak, D. (1980). Silicone rubber sub-
strata: a new wrinkle in the study of cell locomotion. Science 208,
177–179.
Hayashi, K., Yano, H., Hashida, T., Takeuchi, R., Takeda, O., Asada,
K., Takahashi, E., Kato, I., and Sobue, K. (1992). Genomic structure
of the human caldesmon gene. Proc. Natl. Acad. Sci. USA 89,
12122–12126.
Higgins, D.G., Bleasby, A.J., and Fuchs, R. (1991). Clustal V:
improved software for multiple sequence alignment. CABIOS 8,
189–191.
Hodgkinson, J.L., Marston, S.B., Craig, R., Vibert, P., and Lehman,
W. (1997). Three-dimensional image reconstruction of reconstituted
smooth muscle thin filaments: effects of caldesmon. Biophys. J. 72,
2398–2404.
Honer, B., Citi, S., Kendrick-Jones, J., and Jockusch, B.M. (1988).
Modulation of cellular morphology and locomotory activity by
antibodies against myosin. J. Cell Biol. 107, 2181–2189.
Horiuchi, H.Y., Wang, Z., and Chacko, S. (1995). Inhibition of
smooth muscle actomyosin ATPase by caldesmon is associated with
caldesmon-induced conformational changes in tropomyosin bound
to actin. Biochemistry 34, 16815–16820.
Hosoya, N., Hosoya, H., Yamashiro, S., Mohri, H., and Matsumura,
F. (1993). Localization of caldesmon and its dephosphorylation dur-
ing cell division. J. Cell Biol. 121, 1075–1082.
Hotchin, N.A., and Hall, A. (1995). The assembly of integrin adhe-
sion complexes requires both extracellular matrix and intracellular
rho/rac GTPases. J. Cell Biol. 131, 1857–1865.
Huber, P.A. (1997). Caldesmon. Int. J. Biochem. Cell Biol. 29, 1047–
1051.
Ingber, D.E. (1991). Integrins as mechanochemical transducers.
Curr. Opin. Cell. Biol. 3, 841–848.
Ingber, D.E. (1997). Tensegrity: the architectural basis of cellular
mechanotransduction. Annu. Rev. Physiol. 59, 575–599.
Ishizaki, T., Naito, M., Fujisawa, K., Maekawa, M., Watanabe, N.,
Saito, Y., and Narumiya, S. (1997). p160ROCK, a Rho-associated
coiled-coil forming protein kinase, works downstream of Rho and
induces focal adhesions. FEBS Lett. 404, 118–124.
Janssen, R.A., and Mier, J.W. (1997). Tropomyosin-2 cDNA lacking
the 39 untranslated region riboregulator induces growth inhibition
of v-Ki-ras-transformed fibroblasts. Mol. Biol. Cell 8, 897–908.
Jockusch, B.M., et al. (1995). The molecular architecture of focal
adhesions. Annu. Rev. Cell Dev. Biol. 11, 379–416.
Kahn, P., Topp, W.C., and Shin, S. (1983). Tumorigenicity of SV40-
transformed human and monkey cells in immunodeficient mice.
Virology 126, 348–360.
Katsuyama, H., Wang, C.L., and Morgan, K.G. (1992). Regulation of
vascular smooth muscle tone by caldesmon. J. Biol. Chem. 267,
14555–14558.
Kimura, K., et al. (1996). Regulation of myosin phosphatase by Rho
and Rho-associated kinase (Rho-kinase). Science 273, 245–248.
Kolodney, M.S., and Elson, E.L. (1995). Contraction due to micro-
tubule disruption is associated with increased phosphorylation of
myosin regulatory light chain. Proc. Natl. Acad. Sci. USA 92, 10252–
10256.
Lampidis, T.J., Kolonias, D., Savaraj, N., and Rubin, R.W. (1992).
Cardiostimulatory and antiarrhythmic activity of tubulin-binding
agents. Proc. Natl. Acad. Sci. USA 89, 1256–1260.
Leung, T., Chen, X.Q., Manser, E., and Lim, L. (1996). The p160
RhoA-binding kinase ROK alpha is a member of a kinase family and
is involved in the reorganization of the cytoskeleton. Mol. Cell. Biol.
16, 5313–5327.
Lin, J.J., Warren, K.S., Wamboldt, D.D., Wang, T., and Lin, J.L.
(1997). Tropomyosin isoforms in nonmuscle cells. Int. Rev. Cytol.
170, 1–38.
Liu, B.P., Chrzanowska-Wodnicka, M., and Burridge, K. (1998).
Microtubule depolymerization induces stress fibers, focal adhe-
sions, and DNA synthesis via the GTP-binding protein Rho. Cell
Adhes. Commun. 5, 249–255.
MacKenna, D.A., Dolfi, F., Vuori, K., and Ruoslahti, E. (1998). Ex-
tracellular signal-regulated kinase and c-Jun NH2-terminal kinase
activation by mechanical stretch is integrin-dependent and matrix-
specific in rat cardiac fibroblasts. J. Clin. Invest. 101, 301–310.
Majumdar, M., Seasholtz, T.M., Goldstein, D., de Lanerolle, P., and
Brown, J.H. (1998). Requirement for Rho-mediated myosin light
chain phosphorylation in thrombin-stimulated cell rounding and its
dissociation from mitogenesis. J. Biol. Chem. 273, 10099–10106.
Marston, S., et al. (1998). Structural interactions between actin, tro-
pomyosin, caldesmon and calcium binding protein and the regula-
tion of smooth muscle thin filaments. Acta Physiol. Scand. 164,
401–414.
Marston, S.B., Fraser, I.D., Huber, P.A., Pritchard, K., Gusev, N.B.,
and Torok, K. (1994). Location of two contact sites between human
smooth muscle caldesmon and Ca21-calmodulin. J. Biol. Chem. 269,
8134–8139.
Matsumura, F., and Yamashiro, S. (1993). Caldesmon. Curr. Opin.
Cell Biol. 5, 70–76.
McManus, M.J., Lingle, W.L., Salisbury, J.L., and Maihle, N.J. (1997).
A transformation-associated complex involving tyrosine kinase sig-
nal adapter proteins and caldesmon links v-erbB signaling to actin
stress fiber disassembly. Proc. Natl. Acad. Sci. USA. 94, 11351–
11356.
Mezgueldi, M., Derancourt, J., Calas, B., Kassab, R., and Fattoum, A.
(1994). Precise identification of the regulatory F-actin- and calmod-
ulin-binding sequences in the 10-kDa carboxyl-terminal domain of
caldesmon. J. Biol. Chem. 269, 12824–12832.
Novy, R.E., Sellers, J.R., Liu, L.F., and Lin, J.J. (1993). In vitro
functional characterization of bacterially expressed human fibro-
blast tropomyosin isoforms and their chimeric mutants. Cell Motil.
Cytoskeleton. 26, 248–261.
Obara, K., Nikcevic, G., Pestic, L., Nowak, G., Lorimer, D.D., Guer-
riero, V., Jr., Elson, E.L., Paul, R. J., and de Lanerolle, P. (1995).
Fibroblast contractility without an increase in basal myosin light
chain phosphorylation in wild-type cells and cells expressing the
Regulation of Contractility and Adhesion
Vol. 10, October 1999 3111
catalytic domain of myosin light chain kinase. J. Biol. Chem. 270,
18734–18737.
Okagaki, T., Higashi-Fujime, S., Ishikawa, R., Takano-Ohmuro, H.,
and Kohama, K. (1991). In vitro movement of actin filaments on
gizzard smooth muscle myosin: requirement of phosphorylation of
myosin light chain and effects of tropomyosin and caldesmon. J. Bio-
chem. 109, 858–866.
Payne, A.M., Yue, P., Pritchard, K., and Marston, S.B. (1995). Caldes-
mon mRNA splicing and isoform expression in mammalian
smooth-muscle and nonmuscle tissues. Biochem. J. 305, 445–450.
Pelham, R.J., Jr., and Wang, Y. (1997). Cell locomotion and focal
adhesions are regulated by substrate flexibility. Proc. Natl. Acad.
Sci. USA. 94, 13661–13665.
Pfitzer, G., Zeugner, C., Troschka, M., and Chalovich, J.M. (1993).
Caldesmon and a 20-kDa actin-binding fragment of caldesmon in-
hibit tension development in skinned gizzard muscle fiber bundles.
Proc. Natl. Acad. Sci. USA. 90, 5904–5908.
Pittenger, M.F., Kazzaz, J.A., and Helfman, D.M. (1994). Functional
properties of nonmuscle tropomyosin isoforms. Curr. Opin. Cell
Biol. 6, 96–104.
Pittenger, M.F., Kistler, A., and Helfman, D.M. (1995). Alternatively
spliced exons of the beta tropomyosin gene exhibit different affini-
ties for F-actin and effects with nonmuscle caldesmon. J. Cell Sci.
108, 3253–3265.
Prasad, G.L., Fuldner, R.A., and Cooper, H.L. (1993). Expression of
transduced tropomyosin 1 cDNA suppresses neoplastic growth of
cells transformed by the ras oncogene. Proc. Natl. Acad. Sci. USA.
90, 7039–7043.
Pritchard, K., and Marston, S.B. (1991). Ca21-dependent regulation
of vascular smooth-muscle caldesmon by S.100 and related smooth-
muscle proteins. Biochem. J. 277, 819–824.
Ren, X.D., Kiosses, W.B., and Schwartz, M.A. (1999). Regulation of
the small GTP-binding protein Rho by cell adhesion and the cy-
toskeleton. EMBO J. 18, 578–585.
Ridley, A.J., and Hall, A. (1992). The small GTP-binding protein rho
regulates the assembly of focal adhesions and actin stress fibers in
response to growth factors. Cell 70, 389–399.
Schmidt, C., Pommerenke, H., Durr, F., Nebe, B., and Rychly, J.
(1998). Mechanical stressing of integrin receptors induces enhanced
tyrosine phosphorylation of cytoskeletally anchored proteins. J. Biol
Chem. 273, 5081–5085.
Sheridan, B.C., McIntyre, R.C., Jr., Meldrum, D.R., Cleveland, J.C.,
Jr., Agrafojo, J., Banerjee, A., Harken, A.H., and Fullerton, D.A.
(1996). Microtubules regulate pulmonary vascular smooth muscle
contraction. J. Surg. Res. 62, 284–287.
Shirinsky, V.P., Biryukov, K.G., Hettasch, J.M., and Sellers, J.R.
(1992). Inhibition of the relative movement of actin and myosin by
caldesmon and calponin. J. Biol. Chem. 267, 15886–15892.
Sims, J.R., Karp, S., and Ingber, D.E. (1992). Altering the cellular
mechanical force balance results in integrated changes in cell, cy-
toskeletal and nuclear shape. J. Cell Sci. 103, 1215–1222.
Smith, C.W., Pritchard, K., and Marston, S.B. (1987). The mechanism
of Ca21 regulation of vascular smooth muscle thin filaments by
caldesmon and calmodulin. J. Biol. Chem. 262, 116–122.
Soldati, T., and Perriard, J.C. (1991). Intracompartmental sorting of
essential myosin light chains: molecular dissection and in vivo
monitoring by epitope tagging. Cell 66, 277–289.
Somlyo, A.P., and Somlyo, A.V. (1994). Signal transduction and
regulation in smooth muscle. Nature 372, 231–236 (erratum 372,
812).
Squire, J.M., and Morris, E.P. (1998). A new look at thin filament
regulation in vertebrate skeletal muscle. FASEB J. 12, 761–771.
Suter, D.M., Errante, L.D., Belotserkovsky, V., and Forscher, P.
(1998). The Ig superfamily cell adhesion molecule, apCAM, medi-
ates growth cone steering by substrate-cytoskeletal coupling. J. Cell
Biol. 141, 227–240.
Symons, M.H., and Mitchison, T.J. (1992). A GTPase controls cell-
substrate adhesion in Xenopus XTC fibroblasts. J. Cell Biol. 118,
1235–1244.
Tan, J.L., Ravid, S., and Spudich, J.A. (1992). Control of nonmuscle
myosins by phosphorylation. Annu. Rev. Biochem. 61, 721–759.
Tanaka, M., and Herr, W. (1990). Differential transcriptional activa-
tion by Oct-1 and Oct-2: interdependent activation domains induce
Oct-2 phosphorylation. Cell 60, 375–386.
Temm-Grove, C.J., Guo, W., and Helfman, D.M. (1996). Low molec-
ular weight rat fibroblast tropomyosin 5 (TM-5): cDNA cloning,
actin-binding, localization, and coiled-coil interactions. Cell Motil.
Cytoskeleton 33, 223–240.
Tobacman, L.S. (1996). Thin filament-mediated regulation of cardiac
contraction. Annu. Rev. Physiol. 58, 447–481.
Treiman, M., Caspersen, C., and Christensen, S.B. (1998). A tool
coming of age: thapsigargin as an inhibitor of sarco-endoplasmic
reticulum Ca21-ATPases. Trends Pharmacol. Sci. 19, 131–135.
Van Eyk, J.E., Arrell, D.K., Foster, D.B., Strauss, J.D., Heinonen, T.Y.,
Furmaniak-Kazmierczak, E., Cote, G.P., and Mak, A.S. (1998). Dif-
ferent molecular mechanisms for Rho family GTPase-dependent,
Ca21-independent contraction of smooth muscle. J. Biol. Chem. 273,
23433–23439.
Volberg, T., Geiger, B., Citi, S., and Bershadsky, A.D. (1994). Effect of
protein kinase inhibitor H-7 on the contractility, integrity, and mem-
brane anchorage of the microfilament system. Cell Motil. Cytoskel-
eton 29, 321–338.
Wang, Z., and Chacko, S. (1996). Mutagenesis analysis of function-
ally important domains within the C-terminal end of smooth muscle
caldesmon. J. Biol. Chem. 271, 25707–25714.
Wang, Z., Horiuchi, K.Y., and Chacko, S. (1996). Characterization of
the functional domains on the C-terminal region of caldesmon using
full-length and mutant caldesmon molecules. J. Biol. Chem. 271,
2234–2242.
Wang, Z., Jiang, H., Yang, Z.Q., and Chacko, S. (1997). Both N-
terminal myosin-binding and C-terminal actin-binding sites on
smooth muscle caldesmon are required for caldesmon-mediated
inhibition of actin filament velocity. Proc. Natl. Acad. Sci. USA 94,
11899–11891.
Yamashiro, S., Yamakita, Y., Hosoya, H., and Matsumura, F. (1991).
Phosphorylation of nonmuscle caldesmon by p34cdc2 kinase during
mitosis. Nature 349, 169–172.
Yamashiro, S., Yamakita, Y., Yoshida, K., Takiguchi, K., and Mat-
sumura, F. (1995). Characterization of the COOH terminus of non-
muscle caldesmon mutants lacking mitosis-specific phosphoryla-
tion sites. J. Biol. Chem. 270, 4023–4030.
Yamashiro-Matsumura, S., and Matsumura, F. (1988). Characteriza-
tion of 83-kilodalton nonmuscle caldesmon from cultured rat cells:
stimulation of actin binding of nonmuscle tropomyosin and peri-
odic localization along microfilaments like tropomyosin. J. Cell Biol.
106, 1973–1983.
Zhuang, S., Wang, E., and Wang, C.L. (1995). Identification of the
functionally relevant calmodulin binding site in smooth muscle
caldesmon. J. Biol. Chem. 270, 19964–19968.
D.M. Helfman et al.
Molecular Biology of the Cell3112
